1. Home
  2. BIO vs CX Comparison

BIO vs CX Comparison

Compare BIO & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CX
  • Stock Information
  • Founded
  • BIO 1952
  • CX 1906
  • Country
  • BIO United States
  • CX Mexico
  • Employees
  • BIO N/A
  • CX N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CX Building Materials
  • Sector
  • BIO Industrials
  • CX Industrials
  • Exchange
  • BIO Nasdaq
  • CX Nasdaq
  • Market Cap
  • BIO 6.0B
  • CX 10.1B
  • IPO Year
  • BIO N/A
  • CX 1999
  • Fundamental
  • Price
  • BIO $247.21
  • CX $7.28
  • Analyst Decision
  • BIO Strong Buy
  • CX Buy
  • Analyst Count
  • BIO 4
  • CX 5
  • Target Price
  • BIO $324.25
  • CX $7.65
  • AVG Volume (30 Days)
  • BIO 374.0K
  • CX 10.4M
  • Earning Date
  • BIO 07-31-2025
  • CX 07-24-2025
  • Dividend Yield
  • BIO N/A
  • CX 1.16%
  • EPS Growth
  • BIO N/A
  • CX 591.00
  • EPS
  • BIO N/A
  • CX 0.10
  • Revenue
  • BIO $2,541,100,000.00
  • CX $15,906,684,000.00
  • Revenue This Year
  • BIO N/A
  • CX $3.44
  • Revenue Next Year
  • BIO $3.42
  • CX $3.26
  • P/E Ratio
  • BIO N/A
  • CX $7.87
  • Revenue Growth
  • BIO N/A
  • CX N/A
  • 52 Week Low
  • BIO $211.43
  • CX $4.89
  • 52 Week High
  • BIO $387.99
  • CX $7.50
  • Technical
  • Relative Strength Index (RSI)
  • BIO 53.59
  • CX 60.68
  • Support Level
  • BIO $245.87
  • CX $7.17
  • Resistance Level
  • BIO $264.68
  • CX $7.50
  • Average True Range (ATR)
  • BIO 7.33
  • CX 0.18
  • MACD
  • BIO 0.49
  • CX 0.02
  • Stochastic Oscillator
  • BIO 41.12
  • CX 72.89

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

Share on Social Networks: